Journey Medical Corporation DERM

Company Overview

Journey Medical Corporation is a U.S.-based pharmaceutical company focused on the development, acquisition, licensing, and commercialization of prescription dermatology products. The company operates within the dermatology and specialty pharmaceutical industries, with an emphasis on treatments for inflammatory skin conditions, fungal infections, acne, rosacea, actinic keratosis, and other dermatologic disorders. Journey Medical primarily generates revenue through sales of branded prescription products marketed to dermatologists, physicians, and healthcare providers across the United States.

The company’s commercial portfolio has included products such as Qbrexza, Accutane, Amzeeq, Exelderm, and Targadox, among others acquired or licensed through strategic transactions. Journey Medical was formed as a subsidiary of Fortress Biotech, Inc. before becoming a separately traded public company. Its strategy has centered on acquiring or licensing under-promoted or niche dermatology assets and expanding their commercial reach through a focused specialty sales infrastructure. The company’s positioning is supported by its targeted dermatology expertise, relationships with specialty prescribers, and ability to commercialize products without maintaining a broad primary-care sales force.